awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35894882-39D998F6-AA9F-4EE2-8444-EC751449FDDF
Q35894882-39D998F6-AA9F-4EE2-8444-EC751449FDDF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35894882-39D998F6-AA9F-4EE2-8444-EC751449FDDF
Randomized, Multicenter Study of Gefitinib Dose-escalation in Advanced Non-small-cell Lung Cancer Patients Achieved Stable Disease after One-month Gefitinib Treatment.
P2860
Q35894882-39D998F6-AA9F-4EE2-8444-EC751449FDDF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35894882-39D998F6-AA9F-4EE2-8444-EC751449FDDF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
72e6de9b7a17dff56ab0fd3cad3ade98a3afc755
P2860
Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].